Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Vaxcyte Inc (PCVX)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Vaxcyte Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Strategic Advisers U.S. Total Stock 55,750 0.04%
Jan 31, 2025 Strategic Advisers U.S. Total Stock 53,673 0.04%
Dec 31, 2024 Strategic Advisers U.S. Total Stock 55,987 0.04%
Nov 30, 2024 Strategic Advisers U.S. Total Stock 59,926 0.05%
Oct 31, 2024 Strategic Advisers U.S. Total Stock 72,459 0.06%
Sep 30, 2024 Strategic Advisers U.S. Total Stock 75,420 0.06%
Jul 31, 2024 Strategic Advisers U.S. Total Stock 64,000 0.05%
Jun 30, 2024 Strategic Advisers Large Cap 65,000 0.06%
May 31, 2024 Strategic Advisers Large Cap 64,000 0.06%
Apr 30, 2024 Strategic Advisers Large Cap 64,000 0.06%
Mar 31, 2024 Strategic Advisers Large Cap 62,000 0.06%
Feb 29, 2024 Strategic Advisers Large Cap 65,000 0.06%
Jan 31, 2024 Strategic Advisers Large Cap 64,000 0.06%
Dec 31, 2023 Strategic Advisers Large Cap 60,000 0.06%
Oct 31, 2023 Strategic Advisers® Large Cap 61,500 0.06%
Sep 30, 2023 Strategic Advisers® Large Cap 61,508 0.06%
Jul 31, 2023 Strategic Advisers® Large Cap 51,300 0.05%
Jun 30, 2023 Strategic Advisers® Large Cap 51,300 0.05%
Apr 30, 2023 Strategic Advisers® Large Cap 46,200 0.05%

View all ownership details of Vaxcyte Inc